HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Bhargava Selected Research
M Bhargava Research Topics
Disease
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2003 - 07/2000
2
Thalassemia
01/2013 - 10/2007
2
Neoplasms (Cancer)
01/2009 - 07/2005
1
Critical Illness (Critically Ill)
01/2020
1
Venous Thrombosis (Deep-Vein Thrombosis)
01/2020
1
Tuberculosis (Tuberculoses)
06/2018
1
Hereditary Spherocytosis
06/2018
1
Acute Coronary Syndrome
12/2015
1
Coronary Artery Disease (Coronary Atherosclerosis)
12/2015
1
Wounds and Injuries (Trauma)
05/2015
1
Vasculitis (Vasculitides)
03/2014
1
Delta-Beta Thalassemia
01/2013
1
Psoriatic Arthritis
01/2013
1
Retinal Vein Occlusion
02/2012
1
Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
02/2012
1
Microaneurysm
02/2012
1
Hypertensive Retinopathy
02/2012
1
Retinal Hemorrhage
02/2012
1
Retinal Diseases
02/2012
1
Macular Degeneration (Age-Related Maculopathy)
02/2012
1
Macular Edema
02/2012
1
Hypertension (High Blood Pressure)
02/2012
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2011
1
Opportunistic Infections (Opportunistic Infection)
01/2011
1
Osteoarthritis
01/2010
1
Plasma Cell Leukemia
06/2009
1
Squamous Cell Carcinoma of Head and Neck
01/2009
1
beta-Thalassemia (Cooley's Anemia)
10/2007
1
Thrombasthenia (Glanzmann Thrombasthenia)
03/2003
1
Bernard-Soulier Syndrome (Giant Platelet Syndrome)
03/2003
1
Fibrosis (Cirrhosis)
12/2001
1
Hypoxia (Hypoxemia)
12/2001
1
Bacterial Meningitis
11/2001
1
False Aneurysm (Pseudoaneurysm)
12/2000
1
Takayasu Arteritis (Arteritis, Takayasu's)
12/2000
1
Shock
03/2000
1
Hemorrhage
03/2000
Drug/Important Bio-Agent (IBA)
2
Immunoglobulins (Immunoglobulin)
IBA
06/2009 - 07/2000
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2020
1
Pharmaceutical Preparations
IBA
06/2018
1
Pyridoxine (Pyridoxin)
FDA Link
Generic
06/2018
1
Coloring Agents (Dyes)
IBA
06/2018
1
Cytochrome P-450 CYP2C19
IBA
12/2015
1
Cytochrome P-450 CYP3A
IBA
12/2015
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
12/2015
1
Clopidogrel (Plavix)
FDA Link
12/2015
1
Complement System Proteins (Complement)
IBA
03/2014
1
Adalimumab (Humira)
FDA Link
01/2013
1
Fetal Hemoglobin (Hemoglobin F)
IBA
01/2013
1
Retinaldehyde (Retinal)
IBA
02/2012
1
Cytokines
IBA
01/2010
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2009
1
Proteins (Proteins, Gene)
FDA Link
01/2009
1
Staphylococcal Protein A (Protein A)
IBA
01/2009
1
hemoglobin D Punjab
IBA
10/2007
1
Cations
IBA
10/2007
1
DNA (Deoxyribonucleic Acid)
IBA
10/2007
1
Cadherins (E-Cadherin)
IBA
09/2003
1
Arachidonic Acid (Vitamin F)
IBA
03/2003
1
Oxygen (Dioxygen)
IBA
12/2001
1
Esterases
IBA
11/2001
1
multidrug resistance-associated protein 1
IBA
06/2001
1
Messenger RNA (mRNA)
IBA
06/2001
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
07/2000
1
anti-inhibitor coagulant complex
IBA
03/2000
Therapy/Procedure
4
Therapeutics
01/2020 - 10/2011
1
Critical Care (Surgical Intensive Care)
01/2020
1
Total Parenteral Nutrition
01/2020
1
Catheters
01/2020
1
Obstetrical Forceps
05/2015
1
Art Therapy
01/2011
1
Aftercare (After-Treatment)
07/2005
1
Stents
12/2000